ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for IMCR

Stock NameImmunocore Holdings Ltd
TickerIMCR(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS45258D1054
LEI213800IUE3DFS84BVN18

Show aggregate IMCR holdings

News associated with IMCR

Analysts Set Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) PT at $56.89
Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Get Free Report) have earned a consensus recommendation of “Hold” from the eleven analysts that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating […] - 2025-09-15 02:30:24
Immunocore (NASDAQ:IMCR) Coverage Initiated at Jefferies Financial Group
Equities research analysts at Jefferies Financial Group initiated coverage on shares of Immunocore (NASDAQ:IMCR – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “buy” rating and a $48.00 price target on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 47.19% […] - 2025-08-27 02:08:52
Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a […] - 2025-08-18 05:10:58
XTX Topco Ltd Decreases Stock Position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR)
XTX Topco Ltd lessened its position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Free Report) by 3.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 18,192 shares of the company’s stock after selling 704 shares during the quarter. […] - 2025-08-07 05:00:52
Oppenheimer Asset Management Inc. Takes $225,000 Position in Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR)
Oppenheimer Asset Management Inc. bought a new position in shares of Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor bought 7,574 shares of the company’s stock, valued at approximately $225,000. Several other hedge funds and other institutional investors have also modified their holdings of […] - 2025-07-01 04:50:55
GAMMA Investing LLC Increases Stock Position in Immunocore Holdings plc (NASDAQ:IMCR)
GAMMA Investing LLC increased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 3,318.1% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 19,107 shares of the company’s stock after buying an additional 18,548 shares during the quarter. GAMMA Investing LLC’s holdings in Immunocore were worth $5,670,000 as of its […] - 2025-06-10 04:38:58
HC Wainwright Reiterates “Buy” Rating for Immunocore (NASDAQ:IMCR)
Immunocore (NASDAQ:IMCR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $100.00 price target on the stock. HC Wainwright’s price target indicates a potential upside of 158.80% from the stock’s previous close. A number of other […] - 2025-06-04 02:51:03
Immunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Squarepoint Ops LLC
Squarepoint Ops LLC lowered its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 2.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 69,954 shares of the company’s stock after selling 2,114 shares during the quarter. Squarepoint Ops LLC owned about […] - 2025-05-29 05:18:57
Deutsche Bank Aktiengesellschaft Initiates Coverage on Immunocore (NASDAQ:IMCR)
Deutsche Bank Aktiengesellschaft assumed coverage on shares of Immunocore (NASDAQ:IMCR – Get Free Report) in a note issued to investors on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a $65.00 price target on the stock. Deutsche Bank Aktiengesellschaft’s target price indicates a potential upside of 106.41% from the company’s previous close. Other […] - 2025-05-29 02:31:00
Millennium Management LLC Cuts Stake in Immunocore Holdings plc (NASDAQ:IMCR)
Millennium Management LLC reduced its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 15.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 573,362 shares of the company’s stock after selling 103,269 shares during the period. Millennium Management […] - 2025-05-22 05:01:00
BNP Paribas Financial Markets Makes New Investment in Immunocore Holdings plc (NASDAQ:IMCR)
BNP Paribas Financial Markets bought a new position in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 193,115 shares of the company’s stock, valued at approximately $5,697,000. BNP Paribas Financial Markets owned 0.39% of Immunocore as […] - 2025-05-14 06:10:56
Immunocore Holdings plc (NASDAQ:IMCR) Receives $58.13 Consensus PT from Brokerages
Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have earned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to […] - 2025-05-13 02:44:54
Barclays PLC Buys 19,663 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
Barclays PLC increased its stake in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 2,044.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 20,625 shares of the company’s stock after purchasing an additional 19,663 shares during the quarter. Barclays PLC’s holdings in Immunocore were […] - 2025-05-08 04:36:44
Marshall Wace LLP Lowers Stock Holdings in Immunocore Holdings plc (NASDAQ:IMCR)
Marshall Wace LLP lessened its holdings in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 85.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 28,610 shares of the company’s stock after selling 170,833 shares during the quarter. Marshall Wace […] - 2025-05-01 05:43:01
Immunocore Holdings plc (NASDAQ:IMCR) Stake Boosted by Geode Capital Management LLC
Geode Capital Management LLC grew its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 1.2% during the 4th quarter, HoldingsChannel reports. The fund owned 35,492 shares of the company’s stock after acquiring an additional 420 shares during the period. Geode Capital Management LLC’s holdings in Immunocore were worth $1,047,000 as of […] - 2025-05-01 04:32:55
Renaissance Technologies LLC Sells 179,630 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
Renaissance Technologies LLC decreased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 65.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 96,570 shares of the company’s stock after selling 179,630 shares during the period. Renaissance Technologies LLC owned […] - 2025-04-25 05:17:01
Brokerages Set Immunocore Holdings plc (NASDAQ:IMCR) Price Target at $63.73
Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the thirteen brokerages that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have issued a buy recommendation on the company. […] - 2025-04-18 02:28:59
Immunocore Holdings plc (NASDAQ:IMCR) Shares Sold by Orion Portfolio Solutions LLC
Orion Portfolio Solutions LLC lessened its position in Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 37.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,017 shares of the company’s stock after selling 7,675 shares during the period. Orion Portfolio […] - 2025-04-09 05:02:51
Financial Contrast: Immunocore (NASDAQ:IMCR) vs. Creative Medical Technology (NASDAQ:CELZ)
Creative Medical Technology (NASDAQ:CELZ – Get Free Report) and Immunocore (NASDAQ:IMCR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Earnings and Valuation This table compares Creative […] - 2025-04-01 02:57:01
Immunocore Holdings plc (NASDAQ:IMCR) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have earned a consensus rating of “Moderate Buy” from the thirteen analysts that are presently covering the company, Marketbeat reports. One analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and eight have given a buy recommendation to the […] - 2025-03-26 04:56:59
Principal Financial Group Inc. Sells 43,461 Shares of Immunocore Holdings plc (NASDAQ:IMCR)
Principal Financial Group Inc. reduced its position in shares of Immunocore Holdings plc (NASDAQ:IMCR – Free Report) by 8.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 502,857 shares of the company’s stock after selling 43,461 shares during the period. Principal Financial […] - 2025-02-27 07:06:54
Immunocore Holdings plc (NASDAQ:IMCR) Receives Average Rating of “Moderate Buy” from Analysts
Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have received an average recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating […] - 2025-02-04 06:36:58

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) IMCR holdings

DateNumber of IMCR Shares HeldBase Market Value of IMCR SharesLocal Market Value of IMCR SharesChange in IMCR Shares HeldChange in IMCR Base ValueCurrent Price per IMCR Share HeldPrevious Price per IMCR Share Held
2025-12-03 (Wednesday)28,585USD 1,082,800IMCR holding increased by 48881USD 1,082,8000USD 48,881 USD 37.88 USD 36.17
2025-12-02 (Tuesday)28,585IMCR holding increased by 1020USD 1,033,919IMCR holding decreased by -2249USD 1,033,9191,020USD -2,249 USD 36.17 USD 37.59
2025-12-01 (Monday)27,565USD 1,036,168IMCR holding decreased by -52650USD 1,036,1680USD -52,650 USD 37.59 USD 39.5
2025-11-28 (Friday)27,565IMCR holding increased by 68USD 1,088,818IMCR holding decreased by -14637USD 1,088,81868USD -14,637 USD 39.5 USD 40.13
2025-11-27 (Thursday)27,497USD 1,103,455USD 1,103,4550USD 0 USD 40.13 USD 40.13
2025-11-26 (Wednesday)27,497IMCR holding increased by 204USD 1,103,455IMCR holding increased by 15283USD 1,103,455204USD 15,283 USD 40.13 USD 39.87
2025-11-25 (Tuesday)27,293IMCR holding increased by 340USD 1,088,172IMCR holding increased by 45360USD 1,088,172340USD 45,360 USD 39.87 USD 38.69
2025-11-24 (Monday)26,953IMCR holding increased by 68USD 1,042,812IMCR holding decreased by -15113USD 1,042,81268USD -15,113 USD 38.69 USD 39.35
2025-11-21 (Friday)26,885USD 1,057,925IMCR holding increased by 9141USD 1,057,9250USD 9,141 USD 39.35 USD 39.01
2025-11-20 (Thursday)26,885IMCR holding decreased by -272USD 1,048,784IMCR holding decreased by -834USD 1,048,784-272USD -834 USD 39.01 USD 38.65
2025-11-19 (Wednesday)27,157IMCR holding increased by 68USD 1,049,618IMCR holding increased by 18611USD 1,049,61868USD 18,611 USD 38.65 USD 38.06
2025-11-18 (Tuesday)27,089IMCR holding increased by 408USD 1,031,007IMCR holding increased by 55283USD 1,031,007408USD 55,283 USD 38.06 USD 36.57
2025-11-17 (Monday)26,681IMCR holding increased by 136USD 975,724IMCR holding increased by 21431USD 975,724136USD 21,431 USD 36.57 USD 35.95
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IMCR by Blackrock for IE00BYXG2H39

Show aggregate share trades of IMCR

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-02BUY1,02037.81535.805 36.006USD 36,726 32.25
2025-11-28BUY6840.53039.130 39.270USD 2,670 32.19
2025-11-26BUY20440.49039.540 39.635USD 8,086 32.11
2025-11-26BUY20440.49039.540 39.635USD 8,086 32.11
2025-11-25BUY34040.20538.760 38.904USD 13,228 32.08
2025-11-24BUY6840.11538.475 38.639USD 2,627 32.04
2025-11-20SELL-27240.06038.705 38.841USD -10,565 31.98 Loss of -1,867 on sale
2025-11-19BUY6839.07037.640 37.783USD 2,569 31.94
2025-11-18BUY40838.16536.150 36.352USD 14,831 31.91
2025-11-17BUY13637.39035.860 36.013USD 4,898 31.89
2025-11-14BUY6836.69034.800 34.989USD 2,379 31.87
2025-11-12BUY6835.64034.960 35.028USD 2,382 31.83
2025-11-10BUY6735.48033.940 34.094USD 2,284 31.80
2025-11-06BUY6831.75030.500 30.625USD 2,083 31.79
2025-11-04BUY6832.50331.330 31.447USD 2,138 31.80
2025-10-30BUY34033.50032.085 32.226USD 10,957 31.79
2025-10-29BUY13632.85033.855 33.754USD 4,591 31.78
2025-10-22SELL-27232.51033.770 33.644USD -9,151 31.75 Loss of -515 on sale
2025-10-20BUY13633.94033.990 33.985USD 4,622 31.73
2025-10-17BUY33933.56034.220 34.154USD 11,578 31.72
2025-10-15BUY53634.39034.510 34.498USD 18,491 31.70
2025-10-03BUY45534.21035.500 35.371USD 16,094 31.69
2025-10-02BUY6535.29037.000 36.829USD 2,394 31.67
2025-09-30BUY13036.33036.720 36.681USD 4,769 31.62
2025-09-26BUY13034.02035.003 34.905USD 4,538 31.59
2025-09-25BUY13034.08034.340 34.314USD 4,461 31.58
2025-09-24SELL-87734.27035.970 35.800USD -31,397 31.56 Loss of -3,718 on sale
2025-09-18BUY6833.41534.415 34.315USD 2,333 31.55
2025-09-17BUY20433.41534.470 34.365USD 7,010 31.54
2025-08-20SELL-27232.49033.200 33.129USD -9,011 31.51 Loss of -441 on sale
2025-07-30BUY26833.50034.610 34.499USD 9,246 31.46
2025-07-17SELL-13436.21036.360 36.345USD -4,870 31.21 Loss of -688 on sale
2025-07-11SELL-54435.02035.280 35.254USD -19,178 31.10 Loss of -2,260 on sale
2025-07-07BUY20432.41033.355 33.260USD 6,785 31.02
2025-07-02BUY3,74032.75033.950 33.830USD 126,524 30.99
2025-06-13BUY76534.68036.010 35.877USD 27,446 30.93
2025-06-11BUY13035.56037.100 36.946USD 4,803 30.86
2025-06-10BUY13035.93037.560 37.397USD 4,862 30.82
2025-06-04SELL-6537.70039.330 39.167USD -2,546 30.62 Loss of -556 on sale
2025-04-23BUY6529.80030.850 30.745USD 1,998 30.45
2025-04-10SELL-52025.82026.290 26.243USD -13,646 30.72 Profit of 2,327 on sale
2025-04-08SELL-6524.53027.670 27.356USD -1,778 30.84 Profit of 227 on sale
2025-04-07SELL-6526.28027.195 27.103USD -1,762 30.90 Profit of 246 on sale
2025-04-04SELL-32527.26028.555 28.426USD -9,238 30.94 Profit of 816 on sale
2025-04-01BUY27228.63029.670 29.566USD 8,042 30.98
2025-03-31SELL-19529.67029.840 29.823USD -5,815 31.00 Profit of 229 on sale
2025-03-21BUY88429.81030.970 30.854USD 27,275 31.11
2025-03-14SELL-1,00828.80029.840 29.736USD -29,974 31.23 Profit of 1,511 on sale
2025-03-07SELL-12629.80031.200 31.060USD -3,914 31.41 Profit of 44 on sale
2025-03-04SELL-6329.25029.570 29.538USD -1,861 31.47 Profit of 122 on sale
2025-02-25BUY12629.21030.960 30.785USD 3,879 31.64
2025-02-19SELL-6329.77029.930 29.914USD -1,885 31.77 Profit of 117 on sale
2025-02-13BUY18629.74030.050 30.019USD 5,584 31.95
2025-02-12BUY6229.56029.785 29.762USD 1,845 32.00
2025-02-11BUY24828.20530.120 29.929USD 7,422 32.07
2024-12-30SELL-1,78429.03029.370 29.336USD -52,335 32.47 Profit of 5,594 on sale
2024-11-18SELL-1,00531.05031.730 31.662USD -31,820 32.80 Profit of 1,146 on sale
2024-11-08SELL-6734.69034.710 34.708USD -2,325 32.60 Loss of -141 on sale
2024-10-21SELL-6733.31034.620 34.489USD -2,311 0.00 Loss of -2,311 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IMCR

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1915,894038,02341.8%
2025-09-1852,1180130,11640.1%
2025-09-17127,316106336,16637.9%
2025-09-1622,172060,02236.9%
2025-09-1530,923057,07254.2%
2025-09-1264,47710,61392,75369.5%
2025-09-1144,7347,54073,11361.2%
2025-09-1081,26814,616144,41956.3%
2025-09-0943,8220115,26038.0%
2025-09-0857,101100123,99046.1%
2025-09-0564,3340309,44320.8%
2025-09-04111,8840199,05356.2%
2025-09-03182,2607,100246,63673.9%
2025-09-0245,964082,63455.6%
2025-08-2941,259064,53463.9%
2025-08-2831,249093,58633.4%
2025-08-2733,751076,48744.1%
2025-08-2632,058070,61445.4%
2025-08-2532,403084,03738.6%
2025-08-2252,8720149,17235.4%
2025-08-2151,8540227,60622.8%
2025-08-2071,8303,700252,16228.5%
2025-08-1940,3060101,41639.7%
2025-08-1823,909080,11529.8%
2025-08-1527,2950107,89925.3%
2025-08-1469,7830201,28034.7%
2025-08-1351,6530170,85830.2%
2025-08-1286,9910215,47640.4%
2025-08-1197,4080151,74964.2%
2025-08-0890,5600201,91344.9%
2025-08-07146,9850268,46654.7%
2025-08-06255,247482325,75478.4%
2025-08-0527,088357,68747.0%
2025-08-0451,053079,77264.0%
2025-08-01185,6300271,54768.4%
2025-07-3159,3120115,73651.2%
2025-07-3046,7070163,16528.6%
2025-07-2990,14950310,30529.1%
2025-07-2830,648078,81538.9%
2025-07-2547,095315117,71640.0%
2025-07-2418,7001850,45337.1%
2025-07-2367,6130306,22922.1%
2025-07-2249,5600159,35131.1%
2025-07-2141,418089,10946.5%
2025-07-1842,3732,608105,64140.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy